Cristian C. Papazoglu Statescu, MD, PhD

Credentials

Clinical Assistant Professor, Department of Medicine at NYU Grossman School of Medicine
Site Director of Hematology and Medical Oncology Fellowship, Bellevue Cancer Center
Director of Research, Bellevue Cancer Center

Fellowship, Montefiore Medical Center, Albert Einstein College of Medicine, Hematology & Medical Oncology, 2019
Residency, Montefiore Medical Center, Albert Einstein College of Medicine, Internal Medicine, 2016
PhD from SUNY - Stony Brook, 2008
MD from Carol Davila University, 2003

Is this your profile?

Edit profile

Cristian C. Papazoglu Statescu, MD, PhD does not accept insurance.

462 First Avenue, OBV-C&D Building

5th Floor, 556

New York, NY 10016

212-562-1135

212-263-8210

EMBER-4: A Randomized Open-Label Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+ HER2- Early Breast Cancer with an Increased Risk of Recurrence.

Learn More
A Phase II study of Atezolizumab and Bevacizumab in Child-Pugh B7 Hepatocellular Carcinoma.

Learn More
Phase II Trial of Radium-223 Dichloride in Combination with Paclitaxel in Patients with Bone Metastatic Breast Cancer

Learn More

Transcriptional activation by the Mixl1 homeodomain protein in differentiating mouse embryonic stem cells

Zhang, Hailan; Fraser, Stuart T; Papazoglu, Cristian; Hoatlin, Maureen E; Baron, Margaret H

Stem cells. 2009 Dec ; 27(12):2884-95
TAp63 induces senescence and suppresses tumorigenesis in vivo

Guo, Xuecui; Keyes, William M; Papazoglu, Cristian; Zuber, Johannes; Li, Wangzhi; Lowe, Scott W; Vogel, Hannes; Mills, Alea A

Nature cell biology. 2009 Dec ; 11(12):1451-7
CHD5 is a tumor suppressor at human 1p36

Bagchi, Anindya; Papazoglu, Cristian; Wu, Ying; Capurso, Daniel; Brodt, Michael; Francis, Dailia; Bredel, Markus; Vogel, Hannes; Mills, Alea A

Cell. 2007 Feb 09; 128(3):459-75